Cis-urocanic acid suppresses UV-B-induced interleukin-6 and -8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro

Molecular Vision

Volumn 15, Issue , 2009, Pages 1799-1805

  Viiri, J ^a   Jauhonen, H M ^a,b   Kauppinen, A ^a   Ryhanen T ^a   Paimela, T ^a   Hyttinen, J ^a   Sorri, I ^b   Laihia, J K ^c   Leino, L ^c   Kaarniranta, Kai ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c BioCis Pharma Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STRAIN; CELL STRAIN HCE 2; CELL TYPE; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; ULTRAVIOLET B RADIATION;

CASPASE 3; CELL DEATH; CELL LINE; CELL SURVIVAL; CONJUNCTIVA; CULTURE MEDIA; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; ISOMERISM; ULTRAVIOLET RAYS; UROCANIC ACID;

EID: 70149101784     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gibbs NK, Tye J, Norval M. Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochem Photobiol Sci 2008; 7:655-7.
2. Prater MR, Blaylock BL, Holladay SD. Molecular mechanisms of cis-urocanic acid and permethrin-induced alterations in cutaneous immunity. Photodermatol Photoimmunol Photomed 2003; 19:287-94.
3. Lauerma AI, Aioi A, Maibach HI. Topical cis-urocanic acid suppresses both induction and elicitation of contact hypersensitivity in BALB/C mice. Acta Derm Venereol 1995; 75:272-5.
4. Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Mast cells in UVB induced immunosuppression. J Photochem Photobiol B 2000; 55:81-7.
5. el-Ghorr AA, Norval M. The effect of chronic treatment of mice with urocanic acid isomers. Photochem Photobiol 1997; 65:866-72.
6. Kivistö K, Punnonen K, Toppari J, Leino L. Urocanic acid suppresses the activation of human neutrophils in vitro. Inflammation 1996; 20:451-9.
7. Rinaldi M, Moroni P, Leino L, Laihia J, Paape MJ, Bannerman DD. Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species. J Dairy Sci 2006; 89:4188-201.
8. Guymer RH, Mandel TE. Urocanic acid as an immunosuppressant in allotransplantation in mice. Transplantation 1993; 55:36-43.
9. Lu L, Wang L, Shell B. UV-induced signaling pathways associated with corneal epithelial cell apoptosis. Invest Ophthalmol Vis Sci 2003; 44:5102-9.
10. Gaton DD, Lichter H, Avisar I, Slodonovic D. Solomon As. Lymphocytic reaction to ultraviolet radiation on rabbit conjunctiva. Ann Ophthalmol (Skokie) 2007; 39:128-33.
11. Wittenberg S. Solar radiation and the eye: a review of knowledge relevant to eye care. Am J Optom Physiol Opt 1986; 63:676-89.
12. Bielory L. Ocular allergy and dry eye syndrome. Curr Opin Allergy Clin Immunol 2004; 4:421-4.
13. Gilbard JP. The diagnosis and management of dry eyes. Otolaryngol Clin North Am 2005; 38:871-85.
14. Versura P, Profazio V, Cellini M, Torreggiani A, Caramazza R. Eye discomfort and air pollution. Ophthalmologica 1999; 213:103-9.
15. Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjogren syndrome. Ophthalmology 1998; 105:2327-9.
16. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999; 19:201-11.
17. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001; 42:2283-92.
18. Narayanan S, Miller WL, McDermott AM. Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci 2003; 44:3795-801.
19. Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 2007; 26:431-7.
20. Kaneko K, Smetana-Just U, Matsui M, Young AR, John S, Norval M, Walker SL. cis-Urocanic acid initiates gene transcription in primary human keratinocytes. J Immunol 2008; 181:217-24.
21. Holan V, Kuffova L, Zajicova A, Krulova M, Filipec M, Holler P, Jancarek A. Urocanic acid enhances IL-10 production in activated CD4+ T cells. J Immunol 1998; 161:3237-41.
22. Bi Z, Xia J, Ni L. Effects of ultraviolet-irradiated urocanic acid on IL-10 secreted by T lymphocytes. Chin Med J (Engl) 1999; 112:509-11.
23. Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998; 160:3783-9.
24. Hart PH, Jones CA, Jones KL, Watson CJ, Santucci I, Spencer LK, Finlay-Jones JJ. Cisurocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels. J Immunol 1993; 150:4514-23.
25. Redondo P, Garcia-Foncillas J, Cuevillas F, Espana A, Quintanilla E. Effects of low 12 concentrations of cis- and trans-urocanic acid on cytokine elaboration by keratinocytes. Photodermatol Photoimmunol Photomed 1996; 12:237-43.
26. Pauloin T, Dutot M, Joly F, Warnet JM, Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 2009; 15:577-83.
27. Walterscheid JP, Nghiem DX, Kazimi N, Nutt LK, McConkey DJ, Norval M, Ullrich SE. Cisurocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci USA 2006; 103:17420-5.
28. Kim TH, Ihm JE, Choi YJ, Nah JW, Cho CS. Efficient gene delivery by urocanic acidmodified chitosan. J Control Release 2003; 93:389-402.
29. Laihia JK, Pylkkänen L, Laato M, Boström PJ, Leino L. Protodynamic therapy for bladder cancer -in vitro results of a novel treatment concept. BJU Int. 2009
30. Wang C, Wang MW, Tashiro S, Onodera S, Ikejima T. IL-1beta acts in synergy with endogenous IL-1beta in A375-S2 human melanoma cell apoptosis through mitochondrial pathway. J Korean Med Sci 2005; 20:555-61.
31. Salminen A, Ojala J, Suuronen T, Kaarniranta K, Kauppinen A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med 2008; 12:2255-62.
32. Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 2008; 14:S79-87.
33. Versura P, Profazio V, Fresina M, Campos EC. A novel scraping cytology score system (SCSS) grades inflammation in dry eye patients. Curr Eye Res 2009; 34:340-6.
34. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol 2004; 137:337-42.